XML 69 R58.htm IDEA: XBRL DOCUMENT v3.25.0.1
Equity and Stock Compensation Plans - Stock Option Grants, Restricted Stock Units and Unrestricted Stock Grants (Details)
1 Months Ended 12 Months Ended
Feb. 20, 2024
USD ($)
Employee
$ / shares
shares
Jul. 01, 2023
shares
Sep. 30, 2024
shares
Aug. 31, 2024
shares
Dec. 31, 2024
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
$ / shares
shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Number of shares purchased under option exchange program 933,073            
Incremental expense | $         $ 300,000    
Total stock-based compensation expense | $         $ 1,132,000 $ 1,525,000  
Stock options              
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Number of stock options granted         640,000 0  
Options outstanding, Weighted average remaining contractual term (in years)         6 years 7 days    
Weighted average remaining contractual term         3 months    
Aggregate intrinsic value of options exercisable | $         $ 0    
Amount of unrecognized compensation expense related to non-vested options | $         $ 600,000    
Exchange Offer              
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Number of stock options granted         933,073    
Number of employees elected to exchange eligible options | Employee 9            
Number of shares purchased under option exchange program 2,180,000            
Exchange offer, percentage of total shares outstanding 96.00%            
Number of shares forfeited         2,180,000    
New options              
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Exchange offer, percentage of total shares outstanding 50.00%            
Granted exercise price per share | $ / shares $ 2.21            
Incremental expense | $ $ 0            
Restricted Stock Units | 2023 Plan | 2024 Grant              
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Number of shares granted (in shares)         284,814    
Number of shares vested         144,000    
Number of shares forfeited         105,000    
Restricted Stock Units | 2023 Plan | 2024 Grant | June 30, 2024              
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Number of shares vested         70,406    
Restricted Stock Units | 2023 Plan | 2024 Grant | December 31, 2024              
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Number of shares vested         70,408    
Restricted Stock Units | 2023 Plan | 2024 Grant | November 2025              
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Number of shares vested         15,000    
Restricted Stock Units | 2023 Plan | 2024 Grant | December 2024              
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Number of shares vested         6,000    
Restricted Stock Units | 2023 Plan | 2024 Grant | June 2025, 2026 and 2027              
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Number of shares vested         18,000    
Number of shares issued in increments forfeited         6,000    
Unrestricted Stock | 2023 Plan | 2022 Grant              
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Number of shares granted (in shares)       15,000      
Number of shares forfeited     15,000        
Unrestricted Stock | 2023 Plan | 2023 Grant              
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Number of shares granted (in shares)           134,211  
Number of shares issued   67,104       67,107  
Equity Option              
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Number of stock options granted [1]         1,573,073    
Granted exercise price per share | $ / shares [1]         $ 2.14    
Number of shares forfeited         2,257,984 [1] 300,000  
Number of options outstanding         1,575,089 2,260,000 2,560,000
Weighted average exercise price of options outstanding | $ / shares         $ 2.27 $ 4.88 $ 4.96
Options outstanding, Weighted average remaining contractual term (in years)         6 years 11 months 23 days    
Weighted average period for nonvested options           3 years 2 months 12 days  
[1]

(1) Includes 933,073 options granted and 2,180,000 cancelled pursuant to the Exchange Offer.